Policies and Practices Used for the Safe Handling of Antineoplastic Drugs

Anderson R. Puckett W. Dana W. Nguyen D. Theiss J. , & Matney T. (1982). Risk of handling injectable antineoplastic agents. American Journal of Hospital Pharmacy, 39, 1881–1887.

Bartkowski-Dodds L. (1983). Chemotherapy hazard. California Nurse, 78, 5.

Brookshire D. , & Rogers B. (1987). A descriptive study of hospital policies in North Carolina rdgarding the handling of antineoplastic agents. Seminars in Occupational Medicine, 2, 147–154.

Caldwell G. (1977). Second primary malignancies as a delayed result of therapy. Cancer, 40, 1952–1953.

Caudell K. Vredevoe D. Dietrich M. Caudell T. Hoban M. , & Block M. (1988). Quantification of urinary mutagens in nurses during potential adtineoplastic agent exposure: A pilot study with concurrent environmental and dietary control. Cancer Nursing, 11, 41–50.

D'Arcy P. (1983). Reactions and interactions in handling anticancer drugs. Drug Intelligence & Clinical Pharmacy, 17, 532–538.

Falck K. Grohn P. Sorsa M. Vainio H. Heinonen E. , & Holsti L. (1979). Mutagenicity of urine of nurses handling cytostatic drugs. The Lancet, 1, 1250–1251.

Harris C. (1976). The carcinogenicity of anticancer drugs: A hazard in man. Cancer, 37, 1014–1023.

Harrison B. (1981). Developing guidelines for working wih antineoplastic drugs. American Journal of Hospital Pharmacy, 38, 1686–1693.

Hirst M. Mills D. Tse S. , & Levin L. (1984). Occupational exposure to cyclophosphamide. The Lancet, 1, 186–188.

Hoar S. , & Pell S. (1981). A retrospective cohort study of mortality and cancer incidence among chemists. Journal of Occupational Medicine, 23, 485–501.

Hoover R. , & Fraumeni J. (1981). Drug-induced cancer. Cancer, 47, 1071–1080.

Hunt J. (1984). Can we risk finding out? Nursing Mirror, 158, 33–34.

Knowles R. , & Virden J. (1980). Handling of injectable antineoplastic agents. British Medical Journal, 281, 589–591.

Mattia M. , & Blake S. (1983). Hospital hazards: Cancer drugs. American Journal of Nursing, 83, 759–762.

Occupational Safety and Health Administration, Office of Occupational Medicine (1986.) OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. American Journal of Hospital Pharmacy, 43, 1193–1204.

Pape L. (1988). Therapy related acute leukemia—An overview. Cancer Nursing, 11, 295–302.

Rogers B. (1986). Antineoplastic agents—Actions and toxicities. AAOHN Journal, 34(11), 530–538.

Rogers B. (1987). Work practices of nurses who handle antineoplastic agents. AAOHN Journal, 35(1), 24–31.

Rubadue C.L. (1985). Potential health hazards with antineoplastic drugs. Occupational Health Nursing, 33(7), 363–366.

Selvey D. (1985). Cytotoxic drugs: Their handling and use. Nursing Times, 81, 36–38.

Sorsa M. Hemminki K. , & Vainio H. (1985). Occupational exposure to anticancer drugs—Potential and real hazards. Mutation Research, 154, 135–149.

Stolar M. , & Power M. (1984). Safe handling of cytotoxic drugs in hospitals. Quality Review Bulletin, 10, 209–213.

Tortorici M. (1980). Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications. Hospital Pharmacy, 15, 293–301.

Valanis B. , & Browne M. (1985). Use of protection by nurses during occupational handling of antineoplastic drugs. NITA, 8, 218–223.

Venitt S. Crofton-Sleigh C. Hunt J. Speechley V. , & Briggs K. (1984). Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: Urinary mutation assays and urinary platinum as markers of absorption. The Lancet, 1, 74–77.

Waksvik H. Klepp O. , & Brogger A. (1981). Chromosome analysis of nurses handling cytostatic agents. Cancer Treatment Reports, 65, 607–610.

Zimmerman P. Larson R. Barkley E. , & Gallelli J. (1981). Recommendations for the safe handling of injectable antineoplastic drug products. American Journal of Hospital Pharmacy, 38, 1693–1695.